Asset Details
Do you wish to reserve the book?
Association of significantly elevated plasma levels of NGAL and IGFBP4 in patients with diabetic nephropathy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Association of significantly elevated plasma levels of NGAL and IGFBP4 in patients with diabetic nephropathy
Do you wish to request the book?
Association of significantly elevated plasma levels of NGAL and IGFBP4 in patients with diabetic nephropathy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Association of significantly elevated plasma levels of NGAL and IGFBP4 in patients with diabetic nephropathy
2022
Overview
Background
Diabetic nephropathy (DN) is a type of progressive kidney disease affecting approximately 40% of patients with diabetes. Current DN diagnostic criteria predominantly rely on albuminuria and serum creatinine (sCr) levels. However, the specificity and reliability of both markers are limited. Hence, reliable biomarkers are required for early diagnosis to effectively manage DN progression.
Methods
In this study, a cohort of 159 individuals were clinically evaluated and the plasma levels of NGAL, IGFBP-1, IGFBP-3, and IGFBP-4 were determined using Multiplexing Assays. Additionally, the association between the plasma levels of NGAL, IGFBP-1, IGFBP-3, and IGFBP-4 in patients with DN were compared to those in patients with T2D without kidney disease and control participants.
Results
Circulating level of NGAL were significantly higher in people with DN compared to people with T2D and non-diabetic groups (92.76 ± 7.5, 57.22 ± 8.7, and 52.47 ± 2.9 mg/L, respectively;
p
< 0.0001). IGFBP-4 showed a similar pattern, where it was highest in people with DN (795.61 ng/ml ±130.7) compared to T2D and non-diabetic people (374.56 ng/ml ±86.8, 273.06 ng/ml ±27.8 respectively, ANOVA
p
< 0.01). The data from this study shows a significant positive correlation between NGAL and IGFBP-4 in people with DN (
ρ
= .620,
p
< 0.005). IGFBP-4 also correlated positively with creatinine level and negatively with eGFR, in people with DN supporting its involvement in DN.
Conclusion
The data from this study shows a parallel increase in the plasma levels of NGAL and IGFBP-4 in DN. This highlights the potential to use these markers for early diagnosis of DN.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Analysis
/ Diabetes
/ Diabetic Nephropathies - blood
/ Diabetic Nephropathies - diagnosis
/ Female
/ Humans
/ IGFBP-4
/ Insulin-like growth factor 1
/ Insulin-Like Growth Factor Binding Protein 1 - blood
/ Insulin-Like Growth Factor Binding Protein 3 - blood
/ Insulin-Like Growth Factor Binding Protein 4 - blood
/ Insulin-like growth factor-binding protein 1
/ Insulin-like growth factor-binding protein 3
/ Insulin-like growth factor-binding protein 4
/ Male
/ Medicine
/ NGAL
/ Plasma
/ Software
/ Urine
